14.01.2013 Views

Regulation of the dopamine transporter - Addiction Research ...

Regulation of the dopamine transporter - Addiction Research ...

Regulation of the dopamine transporter - Addiction Research ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

DAT <strong>Regulation</strong> Schmitt & Reith<br />

many cytoplasmic-facing consensus sites for phosphorylation,<br />

many <strong>of</strong> which lie on <strong>the</strong> N terminus<br />

<strong>of</strong> <strong>the</strong> DAT protein (for a review <strong>of</strong> functional<br />

moieties in <strong>the</strong> DAT amino acid sequence,<br />

see Volz and Schenk 2 ). Protein phosphorylation is a<br />

de facto posttranslational strategy for regulating protein<br />

function, altering protein–protein interactions<br />

and transducing exogenous stimuli. Because phosphorylation<br />

<strong>of</strong> a particular residue in a protein can<br />

both drastically change its three-dimensional shape<br />

and serve as a signaling marker, is not surprising that<br />

<strong>the</strong> phosphorylation state <strong>of</strong> <strong>the</strong> DAT has a pr<strong>of</strong>ound<br />

influence on both <strong>the</strong> intrinsic activity (i.e., affinity<br />

for and responsiveness to various ligands) and membrane<br />

distribution <strong>of</strong> <strong>the</strong> <strong>transporter</strong>. 4 Several protein<br />

kinases and phosphatases involved in key signaling<br />

cascades can affect DAT function, including<br />

members <strong>of</strong> <strong>the</strong> protein kinase C (PKC), protein kinase<br />

A, phosphatidylinositol-3-kinase (PI3K), protein<br />

tyrosine kinase, Ca 2+ /calmodulin kinase, protein<br />

phosphatase 1, and mitogen-activated protein<br />

kinase (MAPK) families. 49–52 Of <strong>the</strong>se, PKC has been<br />

<strong>the</strong> most thoroughly investigated; however, a direct<br />

phosphotransferase reaction between PKC and <strong>the</strong><br />

DAT has not been demonstrated, suggesting that<br />

o<strong>the</strong>r (currently undefined) downstream kinases<br />

may be responsible for <strong>the</strong> direct phosphorylation<br />

<strong>of</strong> <strong>the</strong> DAT. 4,51 In addition to possible direct effects<br />

on <strong>the</strong> DAT and on DAT membrane trafficking, activation<br />

(or, by <strong>the</strong> same token, inhibition) <strong>of</strong> <strong>the</strong>se<br />

phosphorylation pathways can affect <strong>the</strong> regulatory<br />

and transmitter-releasing action <strong>of</strong> substrates, such<br />

as amphetamine. As we discuss in <strong>the</strong> following,<br />

both substrate exposure and PKC activation can<br />

result in DAT downregulation; however, despite a<br />

myriad <strong>of</strong> studies demonstrating <strong>the</strong> importance<br />

<strong>of</strong> protein kinases and phosphatases in substratemediated<br />

regulation <strong>of</strong> plasmalemmal DAT expression,<br />

explicit details regarding <strong>the</strong> mechanistic link<br />

between <strong>the</strong> two processes have been elusive. 50 In<br />

contrast with substrates, classical DAT inhibitors,<br />

such as cocaine, �-CFT, and methylphenidate, have<br />

little effect on DAT phosphorylation. 48<br />

Protein kinase C<br />

Functional regulation <strong>of</strong> <strong>the</strong> DAT in response to<br />

PKC activation was first demonstrated in vitro by<br />

using phorbol-ester kinase modulators, such as 4�phorbol-12-myristate-13-acetate<br />

(�-PMA). Incubation<br />

with �-PMA (or o<strong>the</strong>r nonphorbol PKC<br />

activators) dramatically increases levels <strong>of</strong> 32 PO4labeled<br />

immunoprecipitated DAT in both synaptosomes<br />

53 and cells heterologously expressing DAT. 54<br />

Increased phosphorylation was not observed in<br />

<strong>the</strong> presence <strong>of</strong> <strong>the</strong> inactive phorbol analogue 4�phorbol-12,13-didecanoate,<br />

and all effects <strong>of</strong> �-<br />

PMA were abolished by cotreatment with <strong>the</strong> PKC<br />

inhibitor bisindoylmaleimide I, highlighting <strong>the</strong> involvement<br />

<strong>of</strong> PKC. 53 Analogous to <strong>the</strong> findings with<br />

DAT substrates, pretreatment with PKC activators<br />

acutely and rapidly reduces [ 3 H]<strong>dopamine</strong> uptake<br />

by lowering <strong>the</strong> V max for uptake without affecting<br />

<strong>the</strong> Km valueandreduces<strong>the</strong>Bmax <strong>of</strong> [ 3 H]mazindol<br />

binding to intact Xenopus oocytes, 55 suggesting a<br />

role for phosphorylation in promoting <strong>the</strong> internalization<br />

<strong>of</strong> plasmalemmal DAT. A follow-up study by<br />

Melikian and Buckley substantiated this hypo<strong>the</strong>sis:<br />

<strong>the</strong> authors found that induction <strong>of</strong> PKC with<br />

�-PMA results in intracellular redistribution <strong>of</strong> <strong>the</strong><br />

DAT from <strong>the</strong> plasma membrane to recycling endosomal<br />

compartments in hDAT-expressing PC12<br />

cells. 56 Endocytic trafficking <strong>of</strong> <strong>the</strong> DAT to early<br />

and recycling endosomes in response to PKC activation<br />

has since been demonstrated in many different<br />

cell models and has been visualized in live cells,<br />

using various fluorescent-tagged DATs. 25,57 PKCmediated<br />

loss <strong>of</strong> plasmalemmal DAT is probably due<br />

to a combination <strong>of</strong> increased clathrin-dependent<br />

endocytosis and decreased recycling from endosomal<br />

compartments. 58 Proteolytic digestion studies<br />

<strong>of</strong> 32 PO4-labeled DAT indicate that serine residues<br />

in <strong>the</strong> N terminus are major target sites <strong>of</strong> phosphorylation<br />

after exogenous pharmacological PKC activation.<br />

59 In both constitutive and PKC-mediated<br />

DAT internalization, an endocytic motif has been<br />

shown to be required in <strong>the</strong> DAT C terminus, that<br />

is, residues 587–596; <strong>the</strong> results do not rule out <strong>the</strong><br />

possibility that o<strong>the</strong>r DAT sequences play a role in<br />

<strong>the</strong> interaction between <strong>the</strong> <strong>transporter</strong> and <strong>the</strong> endocytic<br />

machinery, with such sequences being sensitive<br />

to <strong>the</strong> local environment within <strong>the</strong> 587–596<br />

motif. 60 Essential elements <strong>of</strong> <strong>the</strong> DAT C-terminal<br />

endocytic motif are conserved within <strong>the</strong> SLC6<br />

<strong>transporter</strong> family but not in any o<strong>the</strong>r protein, indicating<br />

that DAT endocytosis may involve a clathrinindependent<br />

component. 60 Recent studies by <strong>the</strong><br />

group <strong>of</strong> Vaughan 61 does not indicate clathrinindependent<br />

endocytosis <strong>of</strong> DAT, but <strong>the</strong>y do<br />

suggest a role for cholesterol-sensitive raftassociated<br />

DAT that responds to PKC with reduced<br />

322 Ann. N.Y. Acad. Sci. 1187 (2010) 316–340 c○ 2010 New York Academy <strong>of</strong> Sciences.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!